Advertisement
Advertisement
April 15, 2014
TriVascular Sets Price and Commences IPO
April 15, 2014—TriVascular Technologies, Inc. (Santa Rosa, CA) announced a price of $12 per share in its initial public offering of 6,500,000 shares of its common stock. The stock begins trading on April 16 on the NASDAQ Global Select Market under the ticker symbol “TRIV.” In addition, TriVascular has granted the underwriters a 30-day option to purchase up to an additional 975,000 shares of common stock at the same price. The offering, which is being made only by a prospectus, is expected to close on April 22, 2014, subject to customary closing conditions.
The company announced on March 10 that it filed a Form S-1 registration statement for this offering with the US Securities and Exchange Commission. The registration was declared effective on April 15, 2014.
TriVascular develops technologies for minimally invasive treatment of abdominal aortic aneurysms, including the FDA-approved Ovation Prime abdominal stent graft system.
Advertisement
Advertisement
